Nombre de los medicamentos: Genérico y Comercial – Aprenda acerca de las causas, los síntomas, el diagnóstico y el tratamiento de los Manuales MSD. Se ha demostrado que los antibióticos aplicados en el párpado alivian los síntomas y resuelven la infección bacteriana de los párpados. Contraindicadas en casos de hipersensibilidad a cualquiera de los antibióticos del grupo de la neomicina (aminoglucósidos), ya que existe sensibilización.
|Published (Last):||23 November 2007|
|PDF File Size:||15.86 Mb|
|ePub File Size:||18.19 Mb|
|Price:||Free* [*Free Regsitration Required]|
Visit 3 Day 5 2. Current or relevant history of physical or psychiatric illness, any medical disorder that may make the subject unlikely to fully complete the study, or any condition that presents undue risk from the investigational product or procedures. Subjects of any age at Visit 1 Note: Absolute and change from baseline of the individual anntibioticos signs bulbar conjunctival injection and ocular conjunctival discharge at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 5.
Nicodemo D, Ferreira LM. Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline as assessed by bacterial culture at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 4. Combination product that includes a device, but does not involve an Advanced Therapy.
Questionnaire of the psychosocial profile of the patient with anophthalmia with indication of ocular prosthesis. Modified clinical resolution status, defined as a global clinical score of 0 or 1, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 7.
Title of the trial for lay people, in easily understood, i. Expanded clinical resolution status, defined as a global clinical score xntibioticos 0, 1, or 2 with neither injection nor discharge having a score of 2, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 8. Las secreciones toman por esta antibiioticos un color verde-azuloso.
Neonates or infants ie. The primary objective of this study is to evaluate the efficacy of SHP based on clinical resolution defined as absence of bulbar conjunctival injection and ocular conjunctival discharge compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5. Trials with results Trials without results. Clinicalfeatures of ocular trauma in emergency departament.
Have any known clinically significant optic nerve defects. Presence of significant, active condition in the posterior segment that requires invasive treatment eg, intravitreal treatment with vascular endothelial growth factor inhibitors or corticosteroids and may progress during the study participation period. The IMP has been designated in this indication as an orphan drug in the Community.
Trials with results Trials without results Clear advanced search filters. Arch Soc Esp Oftalmol. Clinical resolution status defined as absence of bulbar conjunctival injection and ocular conjunctival discharge in the study eye at Visit 3 Day 5 between SHP and placebo. Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition.
Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. Presence of any significant ophthalmic condition eg, Retinopathy of Prematurity, congenital cataract, congenital glaucoma or other congenital disorder with ophthalmic involvement that could affect study variables. Conocimiento, capacidad y voluntad para cumplir plenamente con los procedimientos y restricciones del estudio por los progenitores, tutor o representante legal autorizado, si procede.
Cancer AND drug name. Clear advanced search filters. Sujetos de cualquier edad en la visita 1 Nota: The trial involves single site in the Member State concerned. Time to clinical resolution based upon assessments at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 9. Use of rescue medication Safety Endpoints: Presence of nasolacrimal duct obstruction at Visit 1 Day 1. Have a preplanned overnight hospitalization during the period of the study.
Tener un herpes ocular activo o antecedente. Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Quantitaty eye lid evaluation of anophthalmic cavity carriers with external ocular prosthesis.
Vademécum Académico de Medicamentos
Date on which this record was first entered in the EudraCT database:. Both Female Only Male Only. Review by the Competent Authority or Ethics Committee in the country concerned. Age, sex, causes of eye loss, affected eye, conjunctival disease, type of cavity, length of time of prosthesis use, microbiological result, hygienic handling and response to treatment were the analyzed variables. Pneumonia AND sponsor name. Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Visit 3 Day 5 between SHP and placebo.
The key secondary objective of this study is to evaluate the efficacy of Oftslmicos based on bacterial eradication defined as absence of all bacterial species present at or above pathological threshold at baseline compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5. Full list of Inclusion criteria can be found in the antibioitcos.
A match of Chilean pharma patents to the ISP register
Have active or a history of ocular herpes. Uso de medicamentos de rescate.
Tener una enfermedad ocular significativa p. Key Secondary Efficacy Endpoints: Similarly, most of the anophthalmic cavities are atypical atnibioticos adults with loss of eyeball from traumatism.
Antibloticos global clinical score defined as the sum of bulbar conjunctival injection and ocular conjunctival discharge and change from baseline in the global clinical score at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 6. Clinical resolution status of bacterial conjunctivitis at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 3.
EU Clinical Trials Register. For these items you should use the filters antibikticos not add them to your search terms in the text field. IMP with orphan designation in the indication.